Deeplight Photodynamic therapy system
Pre-clinical- Indications
- Glioblastoma multiforme
Company intelligence / Profile preview
Incando Therapeutics is developing implantable, wireless-powered phototherapy devices for hard-to-treat cancers like glioblastoma and exploring applications in neurodegenerative diseases. The company has not yet reported human clinical results but has ongoing preclinical collaborations with leading academic institutions including Johns Hopkins Medicine to evaluate efficacy in animal models[2][3][5].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Incando Therapeutics.